Endotoxin contamination of nanoparticle formulations: A concern in vaccine adjuvant mechanistic studies

Vaccine. 2023 May 26;41(23):3481-3485. doi: 10.1016/j.vaccine.2023.04.063. Epub 2023 Apr 28.

Abstract

The increasing awareness of endotoxin contamination has raised important questions during the study of the mechanism of action of the vaccine adjuvants. The endotoxins or lipopolysaccharides (LPS) can contaminate vaccine formulations contributing to result misinterpretations of the in vitro and in vivo studies. In this short communication, we considered the suitability of the Limulus amebocyte lysate (LAL) assay to quantify chitosan (Chit) nanoparticle (NP) endotoxin contamination to use them in a comparative in vitro immunotoxicology study using both LPS-free (LF) and non-LF Chit NPs. It was shown that chit NPs had a masking effect on endotoxin levels, hampering a reliable conclusion about the effect of their contamination. Neither non-LF nor LF Chit NPs induced the production of ROS in RAW 264.7 cells or IL-6 and TNF-α in PBMCs. The lack of effect of non-LF NPs was not expected and likely due to the NPs masking effect, more evident for higher deacetylation degree Chit. Overall, to prevent questionable results, nanomaterials should be produced under endotoxin-free conditions.

Keywords: Cytokines; Endotoxin; Limulus amebocyte lysate test; Lipopolysaccharide; Nanoparticle; Peripheral blood mononuclear cells; Reactive oxygen species; Vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Vaccine
  • Endotoxins
  • Limulus Test* / methods
  • Lipopolysaccharides
  • Nanoparticles*

Substances

  • Adjuvants, Vaccine
  • Endotoxins
  • Lipopolysaccharides